Predictors of Survival in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy, Surgery, and Radiotherapy

被引：0
|
作者：
Shao, S. [1 ]
Shi, W. [2 ,3 ,4 ]
Zhang, L. [1 ]
Meng, J. [2 ,3 ,4 ]
Guo, X. M. [2 ,3 ]
Yu, X. [2 ,3 ,4 ]
机构：
[1] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
[2] Fudan Univ, Shanghai Canc Ctr, Dept Radiat, Shanghai, Peoples R China
[3] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China
[4] Shanghai Clin Res Ctr Radiat Oncol, Shanghai, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 120卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2729
引用
收藏
页码：E333 / E333
页数：1
相关论文
共 50 条
  • [41] Response and prognosis of taxanes and anthracyclines neoadjuvant chemotherapy in patients with triple-negative breast cancer
    Jiannan Wu
    Shunrong Li
    Weijuan Jia
    Fengxi Su
    Journal of Cancer Research and Clinical Oncology, 2011, 137 : 1505 - 1510
  • [42] Adjuvant versus neoadjuvant chemotherapy in triple-negative breast cancer patients with BRCA mutations
    Katherine Clifton
    Angelica Gutierrez-Barrera
    Junsheng Ma
    Roland Bassett
    Jennifer Litton
    Henry Kuerer
    Stacy Moulder
    Constance Albarracin
    Gabriel Hortobagyi
    Banu Arun
    Breast Cancer Research and Treatment, 2018, 170 : 101 - 109
  • [43] Adjuvant versus neoadjuvant chemotherapy in triple-negative breast cancer patients with BRCA mutations
    Clifton, Katherine
    Gutierrez-Barrera, Angelica
    Ma, Junsheng
    Bassett, Roland, Jr.
    Litton, Jennifer
    Kuerer, Henry
    Moulder, Stacy
    Albarracin, Constance
    Hortobagyi, Gabriel
    Arun, Banu
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 170 (01) : 101 - 109
  • [44] Predictive factors for the effectiveness of neoadjuvant chemotherapy and prognosis in triple-negative breast cancer patients
    Hiroko Masuda
    Norikazu Masuda
    Yoshinori Kodama
    Masami Ogawa
    Michiko Karita
    Jun Yamamura
    Kazunori Tsukuda
    Hiroyoshi Doihara
    Shinichiro Miyoshi
    Masayuki Mano
    Shoji Nakamori
    Toshimasa Tsujinaka
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 911 - 917
  • [45] Predictors of Survival and Patterns of Recurrence in Breast Cancer Treated with Neoadjuvant Chemotherapy, Surgery, and Radiation
    Keilty, D.
    Namini, S. Nezafat
    Swain, M.
    Maganti, M.
    Cil, T.
    McCready, D. R.
    Cescon, D.
    Amir, E.
    Fleming, R.
    Mulligan, A. M.
    Levin, W.
    Liu, F. F.
    Croke, J. M.
    Fyles, A.
    Koch, C. A.
    Han, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E24 - E25
  • [46] The Immunomodulatory Effects of Dexamethasone on Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer
    Johnson, Kai Conrad Cecil
    Goldstein, Daniel
    Tharakan, Jasmin
    Quiroga, Dionisia
    Kassem, Mahmoud
    Grimm, Michael
    Miah, Abdul
    Vargo, Craig
    Berger, Michael
    Sudheendra, Preeti
    Pariser, Ashley
    Gatti-Mays, Margaret E. E.
    Williams, Nicole
    Stover, Daniel
    Sardesai, Sagar
    Wesolowski, Robert
    Ramaswamy, Bhuvaneswari
    Tozbikian, Gary
    Schnell, Patrick M. M.
    Cherian, Mathew A. A.
    ONCOLOGY AND THERAPY, 2023, 11 (03) : 361 - 374
  • [47] The Immunomodulatory Effects of Dexamethasone on Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer
    Kai Conrad Cecil Johnson
    Daniel Goldstein
    Jasmin Tharakan
    Dionisia Quiroga
    Mahmoud Kassem
    Michael Grimm
    Abdul Miah
    Craig Vargo
    Michael Berger
    Preeti Sudheendra
    Ashley Pariser
    Margaret E. Gatti-Mays
    Nicole Williams
    Daniel Stover
    Sagar Sardesai
    Robert Wesolowski
    Bhuvaneswari Ramaswamy
    Gary Tozbikian
    Patrick M. Schnell
    Mathew A. Cherian
    Oncology and Therapy, 2023, 11 : 361 - 374
  • [48] Triple-Negative Breast Cancer Who Should Receive Neoadjuvant Chemotherapy?
    Chaudhary, Lubna N.
    Wilkinson, K. Hope
    Kong, Amanda
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2018, 27 (01) : 141 - +
  • [49] The PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancer
    Abraham, Jean E.
    Pinilla, Karen
    Dayimu, Alimu
    Grybowicz, Louise
    Demiris, Nikolaos
    Harvey, Caron
    Drewett, Lynsey M.
    Lucey, Rebecca
    Fulton, Alexander
    Roberts, Anne N.
    Worley, Joanna R.
    Chhabra, Anita
    Qian, Wendi
    Vallier, Anne-Laure
    Hardy, Richard M.
    Chan, Steve
    Hickish, Tamas
    Tripathi, Devashish
    Venkitaraman, Ramachandran
    Persic, Mojca
    Aslam, Shahzeena
    Glassman, Daniel
    Raj, Sanjay
    Borley, Annabel
    Braybrooke, Jeremy P.
    Sutherland, Stephanie
    Staples, Emma
    Scott, Lucy C.
    Davies, Mark
    Palmer, Cheryl A.
    Moody, Margaret
    Churn, Mark J.
    Newby, Jacqueline C.
    Mukesh, Mukesh B.
    Chakrabarti, Amitabha
    Roylance, Rebecca R.
    Schouten, Philip C.
    Levitt, Nicola C.
    Mcadam, Karen
    Armstrong, Anne C.
    Copson, Ellen R.
    Mcmurtry, Emma
    Tischkowitz, Marc
    Provenzano, Elena
    Earl, Helena M.
    NATURE, 2024, 629 (8014) : 1142 - 1148
  • [50] Efficacy and prognostic factors of neoadjuvant chemotherapy for triple-negative breast cancer
    Feng Ding
    Ru-Yue Chen
    Jun Hou
    Jing Guo
    Tian-Yi Dong
    World Journal of Clinical Cases, 2022, 10 (12) : 3698 - 3708
12345